Drug Type Small molecule drug |
Synonyms PF 5175157, PF-5175157 |
Target |
Mechanism ACC inhibitors(Acetyl-CoA carboxylase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H27N5O2 |
InChIKeyBDXXSFOJPYSYOC-UHFFFAOYSA-N |
CAS Registry1301214-47-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acne Vulgaris | Phase 2 | - | 01 Apr 2014 | |
Diabetes Mellitus, Type 2 | Phase 2 | US | 01 Dec 2012 | |
Obesity | Phase 1 | US | 01 Oct 2012 | |
Diabetes Mellitus, Noninsulin-Dependent, 2 | Phase 1 | US | 01 Jul 2011 |
Phase 2 | 19 | insulin (All Participants in Part A) | jckwmbkfbj(hxwnydrbwu) = kdvzcryhwq divxjfpwsj (iaxhbrovxf, rsgcjypnaq - bhpsjsljoo) View more | - | 16 Feb 2017 | ||
Placebo (Placebo - Part B) | cyveosastc(vgjyinihej) = hebownnzpp mmzkytoxvy (qqsbigqbhn, vvvhvykrnk - jjzfnmcmma) View more | ||||||
Phase 1 | 64 | Placebo (Placebo - HOV) | sjmihayjtc(rvkxzheymn) = txgjqcbukv paivlzcdns (osvhvyywkh, ctzeugjvcc - ooqjzynyos) View more | - | 06 Nov 2016 | ||
Placebo (Placebo - T2DM) | sjmihayjtc(rvkxzheymn) = qeaevgdyvc paivlzcdns (osvhvyywkh, rzjgyqovvo - mxzxjhllwc) View more | ||||||
Phase 1 | - | 12 | Placebo | qdfzqcaxjq(ecayrupqxv) = ddfxsywlzz hdzovswtmw (xxbtcdzwjm, svesgisoua - azyhbllicx) View more | - | 02 May 2016 |